Jakob Dupont

ATRA

Jakob Dupont serves as EVP, Head of R&D at Atara Biotherapeutics, Inc. (ATRA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

12 trades

$573.0K

Net Position

Net Seller

$573.0K

Companies Traded

ATRA

Active Period

May 2021 – Mar 2023

12 total trades

Most Recent

Sell ATRA

Mar 2, 2023 · $18.4K

Jakob Dupont's Insider Trading at Atara Biotherapeutics, Inc. (ATRA)

Buys

0 · $0.00

Sells

12 · $573.0K

Total Shares Bought

Total Shares Sold

49,169

ATRA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 2, 2023	Sell	5,074	$3.63	$18.4K
Nov 16, 2022	Sell	4,342	$4.49	$19.5K
Aug 16, 2022	Sell	4,124	$5.03	$20.8K
May 17, 2022	Sell	3,873	$5.32	$20.6K
Mar 1, 2022	Sell	2,221	$9.86	$21.9K
Feb 10, 2022	Sell	5,000	$16.00	$80.0K
Jan 3, 2022	Sell	5,000	$16.01	$80.0K
Dec 1, 2021	Sell	5,000	$17.94	$89.7K
Nov 16, 2021	Sell	2,199	$17.12	$37.6K
Nov 2, 2021	Sell	5,000	$16.41	$82.0K
Aug 17, 2021	Sell	2,152	$12.53	$27.0K
May 18, 2021	Sell	5,184	$14.55	$75.4K

Related Insiders

Panacea Innovation Ltd

10 percent owner

ATRASell · Jan 14, 2026

Yanina Grant-Huerta

Chief Accounting Officer

ATRASell · Nov 17, 2025

AnhCo Nguyen

President and CEO

ATRASell · Nov 17, 2025

Explore More Insider Trading Data

ATRA Insider Trading Activity

View all insider trades at Atara Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity